Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study
ProVal-MS 研究是一项前瞻性研究，旨在验证一种多维度治疗决策评分预测未经治疗的临床孤立综合征和早期复发缓解型多发性硬化症患者 24 个月预后的有效性。
期刊:Neurological Research and Practice
影响因子:3.2
doi:10.1186/s42466-024-00310-x
Bayas, Antonios; Mansmann, Ulrich; Ön, Begum Irmak; Hoffmann, Verena S; Berthele, Achim; Mühlau, Mark; Kowarik, Markus C; Krumbholz, Markus; Senel, Makbule; Steuerwald, Verena; Naumann, Markus; Hartberger, Julia; Kerschensteiner, Martin; Oswald, Eva; Ruschil, Christoph; Ziemann, Ulf; Tumani, Hayrettin; Vardakas, Ioannis; Albashiti, Fady; Kramer, Frank; Soto-Rey, Iñaki; Spengler, Helmut; Mayer, Gerhard; Kestler, Hans Armin; Kohlbacher, Oliver; Hagedorn, Marlien; Boeker, Martin; Kuhn, Klaus; Buchka, Stefan; Kohlmayer, Florian; Kirschke, Jan S; Behrens, Lars; Zimmermann, Hanna; Bender, Benjamin; Sollmann, Nico; Havla, Joachim; Hemmer, Bernhard
